Sijme Zeilemaker
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Sijme Zeilemaker
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
21
| Public Company | Biotechnology | 21 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Sijme Zeilemaker tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
| ACTIVE BIOTECH AB | Biotechnology | Chief Executive Officer Chief Executive Officer | |
| MEDIVIR AB | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Organon NV
 Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Van Herk Investments BV
 Van Herk Investments BV Investment ManagersFinance Van Herk Investments BV (VHI) is the private equity investment arm of the Van Herk Groep BV, based in Rotterdam. The parent firm was established in the 1950s as a family business with a focus on real estate investments. VHI invests in listed and unlisted firms across diverse sectors primarily in The Netherlands. | Investment Managers | Director of Finance/CFO Private Equity Investor | |
| ALLENEX AB | Biotechnology | Chief Operating Officer | |
NM Pharma AS
 NM Pharma AS Pharmaceuticals: MajorHealth Technology NM Pharma AS manufactures and markets generic pharmaceuticals. It produces anti-inflammatory and cardiovascular agents and other prescription medicines and consumer health care products. The company is headquartered in Oslo, Norway | Pharmaceuticals: Major | Chief Executive Officer | |
| Chalmers University of Technology | College/University | Graduate Degree | |
| Stockholm School of Economics | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| University of Uppsala | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
| University of Amsterdam | College/University | Graduate Degree | |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Lund | College/University | Doctorate Degree Undergraduate Degree | |
| Erasmus University Rotterdam | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| University of Leiden | College/University | Doctorate Degree | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
Hansen Conference & Event AB
 Hansen Conference & Event AB Miscellaneous Commercial ServicesCommercial Services Hansen Conference & Event AB provides event planning services. The firm's services by type include conference trip, conference, congress, field trip and incentive travel. The company was founded in 1989 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Bactiguard AB
 Bactiguard AB Medical DistributorsDistribution Services Bactiguard AB develops and supplies infection protection solutions to reduce the risk of hospital and healthcare related infections. Its product portfolio, Bactiguard Infection Protection, prevents bacterial adhesion and biofilm formation on medical devices. The firm's products include Infection Prevention Foley Catheter, Central Venous Catheter, and Endotracheal Tube. The company was founded by Nils Peder Christian Kinch on June 13, 2005 and is headquartered in Stockholm, Sweden. | Medical Distributors | Corporate Officer/Principal | |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Medical Specialties | Corporate Officer/Principal | |
Organon Pharmaceuticals USA, Inc.
 Organon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Organon Pharmaceutical USA, Inc. markets and distributes pharmaceutical products. Its products include contraceptives and anesthetics, as well as treatments for mental health disorders. The company is headquartered in Roseland, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Likvor AB
 Likvor AB Medical SpecialtiesHealth Technology Likvor AB engages in the manufacture and development of medical devices for neurological investigations. The firm offers Celda System and Celda Tools, a medical device that simplifies the mapping and assessment of cerebrospinal fluid dynamics. Its product package also features complementary instruments, tools, and software tools. The company was founded in 2007 and is headquartered in Umea, Sweden. | Medical Specialties | Chairman | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Probac AB
 Probac AB Pharmaceuticals: MajorHealth Technology Probac AB manufactures, markets, and licenses probiotic products. Its product development takes place in three different areas: ear-nose-throat; gastrointestinal tract; and the immune system. The firm offers probiotic strains designed for different applications in provisions and pharmaceuticals. Its product Probactiv svalg, contains bacteria normally present in the throat. The company was founded by Eva Grahn Hakansson and Waldemar Nyström in 2005 and is headquartered in Umea, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
InteRNA Technologies BV
 InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Biotechnology | Director/Board Member | |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| LFF Service AB | Chief Executive Officer | ||
| Farmos Group AB | Chief Executive Officer | ||
| Cilag AB | Chief Executive Officer | ||
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Mylan AB
 Mylan AB Pharmaceuticals: MajorHealth Technology Mylan AB manufactures pharmaceutical products. The company is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
| CANTARGIA AB | Pharmaceuticals: Major | Chairman Director/Board Member Chairman | |
Biomatcell AB
 Biomatcell AB BiotechnologyHealth Technology Biomatcell AB operates as a holding company that commercializes inventions in the fields of biomaterial science and cell therapy by licensing its inventions and creating spin-off companies. It develops three-dimensional biomaterial scaffold geometries in bioactive ceramics and metals. It markets products and services based on research in the field of biomaterials and stem cells and patenting new ideas in the same area. The company was founded on May 11, 2004 and is headquartered in Gothenburg, Sweden. | Biotechnology | Chairman | |
DCPrime BV
 DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Undergraduate Degree | |
| Ireya Consulting BV | Corporate Officer/Principal | ||
SkylineDx BV
 SkylineDx BV Medical/Nursing ServicesHealth Services SkylineDx BV develops molecular diagnostic tests for blood cancers. The firm focuses on the development and commercialization of gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. Its products include MMprofiler and AMLprofiler. The company was founded by Dharminder S. Chahal and Bob Löwenberg in 2005 and is headquartered in Rotterdam, the Netherlands. | Medical/Nursing Services | Director/Board Member Chief Executive Officer | |
| CORLINE BIOMEDICAL AB | Medical Specialties | Director/Board Member Director/Board Member | |
| Aduro Biotech Europe BV | Chief Tech/Sci/R&D Officer | ||
Sensara BV
 Sensara BV Internet Software/ServicesTechnology Services Sensara BV engages in the development of self-learning, intelligent home monitoring solutions for the home care industry. It offers a smart sensor system, which detects unusual situations and sounds an alarm when something is wrong. The company was founded by Irek Karkowski and Ted Punt and is headquartered in Rotterdam, the Netherlands. | Internet Software/Services | Director/Board Member | |
| ECTIN RESEARCH AB | Biotechnology | Director/Board Member Chairman | |
| ELICERA THERAPEUTICS AB | Biotechnology | Chairman Director/Board Member | |
Abata Therapeutics, Inc.
 Abata Therapeutics, Inc. BiotechnologyHealth Technology Abata Therapeutics, Inc. is a biotech company based in Watertown, MA. Abata Therapeutics is focused on developing engineered Treg cell therapies for severe autoimmune and inflammatory diseases. The American company's lead programs are in ind-enabling studies for progressive multiple sclerosis and type 1 diabetes, both of which are tissue-specific autoimmune diseases with significant unmet needs. The company has developed a differentiated product engine to create tissue-specific, robust, and durable therapies. Abata Therapeutics was launched by Third Rock Ventures, with participation from a diverse syndicate of investors, including ElevateBio, Lightspeed Venture Partners, Invus, Samsara Biocapital, and the JDRF T1D Fund. The company was founded in 2021 by Richard Ransohoff and the CEO is Samantha Singer. | Biotechnology | Private Equity Investor | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor |
Statistiche
Distribuzione geografica
| Svezia | 26 |
| Paesi Bassi | 13 |
| Stati Uniti | 9 |
| Norvegia | 2 |
| Regno Unito | 2 |
Settori
| Health Technology | 28 |
| Consumer Services | 9 |
| Finance | 4 |
| Commercial Services | 3 |
| Health Services | 3 |
Posizioni
| Director/Board Member | 135 |
| Corporate Officer/Principal | 68 |
| Chairman | 49 |
| Chief Executive Officer | 45 |
| Independent Dir/Board Member | 37 |
Contatti più connessi
| Insiders | |
|---|---|
| Gunnar Magnus Modee Persson | 51 |
| Eva Agneta Edberg | 45 |
| Dharminder Singh Chahal | 25 |
| Sven Arne Andréasson | 24 |
| Sven Rohmann | 20 |
| Magnus Nilsson | 19 |
| Kerstin Valinder-Strinnholm | 18 |
| Lars Martin Lindström | 16 |
| Andrea van Elsas | 16 |
| Erik Esveld | 15 |
| Carlos de Sousa | 14 |
| Christine Lind | 13 |
| Michael Oredsson | 12 |
| Hans Preusting | 10 |
| Margareth Jorvid | 9 |
- Borsa valori
- Insiders
- Sijme Zeilemaker
- Connessioni Società
